Learn More
In the current study, we tested the potential anti-pancreatic cancer activity of a novel hydroxamate-based histone deacetylase (HDAC) inhibitor ST-3595. We showed that ST-3595 exerted potent anti-proliferative and cytotoxic activities against both established pancreatic cancer cell lines (PANC-1, AsPC-1, and Mia-PaCa-2), and patient-derived primary cancer(More)
Background: The feasibility of binding pancreaticogastrostomy in laparoscopic central pancreatectomy is not known. Methods: In October 2011, a female patient with a pancreatic neck mass received laparoscopic central pancreatectomy with binding pancreaticogastrostomy. Results: The operation was successful. No complications occurred. The operative time was(More)
  • 1